Results 311 to 320 of about 52,848 (330)

Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.

Current pharmaceutical design, 2001
Bengt Danielsson, A. Sköld, F. Azarbayjani   +2 more
semanticscholar   +1 more source

Antiarrhythmics

Reactions Weekly, 2020
openaire   +2 more sources

Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

American Heart Journal, 2002
M. Brodsky, L. Mitchell, B. Halperin, M. Raitt, A. Hallstrom, A. Investigators   +5 more
semanticscholar   +1 more source

Antiarrhythmics

2018
Mathew George, Lincy Joseph, Sujith K
openaire   +2 more sources

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study

, 2001
J. Steinberg, J. Martins, S. Sadanandan, B. Goldner, E. Menchavez, M. Domanski, A. Russo, N. Tullo, A. Hallstrom   +8 more
semanticscholar   +1 more source

Partner Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial

Journal of Cardiovascular Nursing, 2007
L. Jenkins, J. Powell, E. Schron, M. McBurnie, Susan Bosworth-Farrell, Rich Moore, D. Exner   +6 more
semanticscholar   +1 more source

Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable d

American Heart Journal, 2001
D. Exner, R. Sheldon, S. Pinski, J. Kron, A. Hallstrom   +4 more
semanticscholar   +1 more source

Oral class III antiarrhythmics: what is new?

Current Opinion in Cardiology, 2004
Mazhar H. Khan
semanticscholar   +1 more source

Antiarrhythmics

Reactions, 1989
openaire   +2 more sources

Antiarrhythmic Agents

2009
openaire   +1 more source